American Society for Investigative Pathology to honor Qing Zhang, PhD

April 17, 2019

The American Society for Investigative Pathology has named UNC Lineberger member Qing Zhang, PhD, associate professor in the Department of Pathology and Laboratory Medicine, as the recipient of the 2020 ASIP Cotran Early Career Investigator Award. This award recognizes individuals in the early stages of their career who have demonstrated excellence as investigators and have … Continued

Studies explore mechanisms behind obesity-cancer link

March 31, 2019

New studies led by University of North Carolina Lineberger Comprehensive Cancer Center researchers explore biological mechanisms behind obesity and its link with cancer. Research findings presented at the American Association for Cancer Research Annual Meeting 2019 explore possible reasons for obesity-related resistance to breast cancer treatment and possible strategies to overcome obesity-related immune suppression in … Continued

Scientists discover key enzyme in breast cancer proliferation, treatment resistance

March 12, 2019

Basal-like breast cancer is the most aggressive and difficult-to-treat subtype of breast cancer, and it largely overlaps with the triple-negative classification of the disease. Patients are in dire need of improved therapies that attack the underlying cellular features of these types of breast cancer. Now scientists at the University of North Carolina Lineberger Comprehensive Cancer … Continued

World traveler finds cancer is just another mountain to climb

February 25, 2019

For a seasoned traveler like Anita McAllister, you’d think exploring the mountainous terrain around Machu Picchu was the most memorable and challenging experience of her life. But a breast cancer diagnosis sent her on a new journey, one that has expanded her horizons beyond the mountains of Peru and has given her a new purpose. … Continued

Researchers identify driver of a key change in metastatic breast cancer

January 24, 2019

In preliminary findings presented at the 2018 San Antonio Breast Cancer Symposium, researchers led by UNC Lineberger’s Charles M. Perou, PhD, and Susana Garcia-Recio, PhD, reported they found increased expression of the gene FGFR4 in metastatic breast cancer tumors.